Skip to Content

M 40 (Clorazepate 7.5 mg)

Pill imprint M 40 has been identified as Clorazepate dipotassium 7.5 mg.

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Clorazepate dipotassium 7.5 mg M 40
Clorazepate dipotassium 7.5 mg M 40  Front
Clorazepate dipotassium 7.5 mg M 40  Back
Clorazepate dipotassium 7.5 mg M 40
Clorazepate dipotassium
M 40
7.5 mg
8.00 mm
Prescription only
Drug Class:
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
FD&C Yellow No. 6
magnesium oxide
magnesium stearate
microcrystalline cellulose
potassium carbonate
sodium chloride
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49999-0674 Lake Erie Medical and Surgical Supply (repackager)
67544-0018 Prepak Systems Inc (repackager)
16590-0759 Stat RX USA LLC (repackager)
43063-0164 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.